相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Increased platelet content of SDF-1alpha is associated with worse prognosis in patients with pulmonary prterial hypertension
Remigiusz Kazimierczyk et al.
PLATELETS (2019)
Toll-like Receptor 3 Is a Therapeutic Target for Pulmonary Hypertension
Daniela Farkas et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension
Diederik E. Van der Feen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in pulmonary Arteria Hypenension
Alice Bourgeois et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Astrid Weiss et al.
NATURE COMMUNICATIONS (2019)
Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure
Colin M. Suen et al.
CARDIOVASCULAR RESEARCH (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Genetics and genomics of pulmonary arterial hypertension
Nicholas W. Morrell et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Clinical trial design and new therapies for pulmonary arterial hypertension
Olivier Sitbon et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
Andrew J. Bryant et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs
Cheng-Cheng Shen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
A guide to chemokines and their receptors
Catherine E. Hughes et al.
FEBS JOURNAL (2018)
Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress
Joanna Costa et al.
INFLAMMATION (2018)
Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes
Jonathan Florentin et al.
JOURNAL OF IMMUNOLOGY (2018)
CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation
Xiaowei Nie et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Expression of angiogenic factors and plexiform lesions in the lungs of broiler and layer chickens: A comparison1
X. Tan et al.
POULTRY SCIENCE (2018)
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Anna-Maria Hoffmann-Vold et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers
Akylbek Sydykov et al.
FRONTIERS IN PHYSIOLOGY (2018)
The unique structural and functional features of CXCL12
Rik Janssens et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension
Sharon Mumby et al.
RESPIROLOGY (2017)
Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function
You-Hong Cheng et al.
PLOS ONE (2017)
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
Timothy G. Pestell et al.
ONCOTARGET (2017)
Cigarette Smoke Increases Endothelial CXCL16-Leukocyte CXCR6 Adhesion In Vitro and In Vivo. Potential Consequences in Chronic Obstructive Pulmonary Disease
Patrice Marques et al.
FRONTIERS IN IMMUNOLOGY (2017)
The cancer theory of pulmonary arterial hypertension
Olivier Boucherat et al.
PULMONARY CIRCULATION (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Baicalin attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2A receptor-induced SDF-1/CXCR4/PI3K/AKT signaling
Xiaoying Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension
Valerie Amsellem et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Bone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension
Ling Yan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Role of CX3CL1 in Diseases
WangMi Liu et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α
Zhiyu Dai et al.
CIRCULATION (2016)
Review DNA Damage and Pulmonary Hypertension
BenoOt Ranchoux et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors
Jeffrey S. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Enrichment of Cdk1-cyclins at DNA double-strand breaks stimulates Fun30 phosphorylation and DNA end resection
Xuefeng Chen et al.
NUCLEIC ACIDS RESEARCH (2016)
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis
Jonathan D. W. Evans et al.
LANCET RESPIRATORY MEDICINE (2016)
CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Karen M. Olsson et al.
RESPIRATORY RESEARCH (2016)
Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
Robert B. Good et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Chemokine receptors and their therapeutic opportunities in diseased lung: Far beyond leukocyte trafficking
Tereza Tomankova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
Morane Le Hiress et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Bone Morphogenetic Protein Receptor Type II Deficiency and Increased Inflammatory Cytokine Production
Elaine Soon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Bromodomain-Containing Protein 4 The Epigenetic Origin of Pulmonary Arterial Hypertension
Jolyane Meloche et al.
CIRCULATION RESEARCH (2015)
Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects
Yasuaki Kishimoto et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2015)
TNF-α-stimulated fibroblasts secrete lumican to promote fibrocyte differentiation
Darrell Pilling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
Takahiro Hashimoto-Kataoka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia
Liuping Wei et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2015)
Potential Contribution of Phenotypically Modulated Smooth Muscle Cells and Related Inflammation in the Development of Experimental Obstructive Pulmonary Vasculopathy in Rats
Shoichiro Otsuki et al.
PLOS ONE (2015)
Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension
Brian N. McCullagh et al.
PLOS ONE (2015)
Endothelin-1 Activation of the Endothelin B Receptor Modulates Pulmonary Endothelial CX3CL1 and Contributes to Pulmonary Angiogenesis in Experimental Hepatopulmonary Syndrome
Junlan Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Hypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertension
Kazuyo Yamaji-Kegan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Targeted Delivery of Pulmonary Arterial Endothelial Cells Overexpressing Interleukin-8 Receptors Attenuates Monocrotaline-Induced Pulmonary Vascular Remodeling
Jinyan Fu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
CCR5 as a Treatment Target in Pulmonary Arterial Hypertension
Valerie Amsellem et al.
CIRCULATION (2014)
Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension
Peter M. George et al.
CIRCULATION RESEARCH (2014)
MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts
Daren Wang et al.
CIRCULATION RESEARCH (2014)
Comprehensive analysis of inflammatory markers in chronic thrornboembolic pulmonary hypertension patients
Diana Zabini et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension
Tao Yang et al.
HEART & LUNG (2014)
Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension
Hirofumi Sawada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats
Zhibin Yuan et al.
PLOS ONE (2014)
CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit+ Cells in Rats
Daniela Farkas et al.
PLOS ONE (2014)
Novel Mechanisms of Sildenafil in Pulmonary Hypertension Involving Cytokines/Chemokines, MAP Kinases and Akt
Tamas Kiss et al.
PLOS ONE (2014)
Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure models
John E. S. Park et al.
THORAX (2014)
Effect of Aspirin on Fractalkine in Rats with Pulmonary Embolism
Ling-Cong Wang et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2014)
A modified Glenn shunt reduces venous congestion during acute right ventricular failure due to pulmonary banding: a randomized experimental study
Per Vikholm et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2014)
Endothelial GATA-6 Deficiency Promotes Pulmonary Arterial Hypertension
Angela Ghatnekar et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
CCR2 Deficiency, Dysregulation of Notch Signaling, and Spontaneous Pulmonary Arterial Hypertension
Yen-Rei A. Yu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
SDF-1α in Glycan Nanoparticles Exhibits Full Activity and Reduces Pulmonary Hypertension in Rats
Tao Yin et al.
BIOMACROMOLECULES (2013)
Gene expression levels of cytokines in peripheral blood mononuclear cells from patients with pulmonary embolism
Wei Lv et al.
MOLECULAR MEDICINE REPORTS (2013)
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension
Jongmin Kim et al.
NATURE MEDICINE (2013)
Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension
Laura C. Price et al.
PLOS ONE (2013)
Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium
Cristina Rius et al.
THORAX (2013)
Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion
Jianliang Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines
Rachel J. Davies et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)
Pulmonary Lymphoid Neogenesis in Idiopathic Pulmonary Arterial Hypertension
Frederic Perros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension
Rajkumar Savai et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Viral Toll Like Receptor activation of pulmonary vascular smooth muscle cells results in endothelin-1 generation; relevance to pathogenesis of pulmonary arterial hypertension
Peter M. George et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
BMP9 regulates endoglin-dependent chemokine responses in endothelial cells
Kira Young et al.
BLOOD (2012)
A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease
Christine M. Costello et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Chemokines regulate small leucine-rich proteoglycans in the extracellular matrix of the pressure-overloaded right ventricle
Anne Waehre et al.
JOURNAL OF APPLIED PHYSIOLOGY (2012)
The role of CX3CL1/CX3CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome
Junlan Zhang et al.
JOURNAL OF HEPATOLOGY (2012)
Circulating Cytokines and Growth Factors in Pediatric Pulmonary Hypertension
Mark Duncan et al.
MEDIATORS OF INFLAMMATION (2012)
Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction
Diana Zabini et al.
PLOS ONE (2012)
Effect of Different Interferonα2 Preparations on IP10 and ET-1 Release from Human Lung Cells
Rekha Badiger et al.
PLOS ONE (2012)
Antagonism of CXCR7 attenuates chronic hypoxia-induced pulmonary hypertension
Ecaterina Sartina et al.
PEDIATRIC RESEARCH (2012)
Lack of CCR7 induces pulmonary hypertension involving perivascular leukocyte infiltration and inflammation
Karl-Otto Larsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Interferon and Alternative Activation of Monocyte/Macrophages in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Romy B. Christmann et al.
ARTHRITIS AND RHEUMATISM (2011)
Attenuation of leukocyte recruitment via CXCR1/2 inhibition stops the progression of PAH in mice with genetic ablation of endothelial BMPR-II
Victoria J. Burton et al.
BLOOD (2011)
Targeting of c-kit plus haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
N. Gambaryan et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Emergence of Fibroblasts with a Proinflammatory Epigenetically Altered Phenotype in Severe Hypoxic Pulmonary Hypertension
Min Li et al.
JOURNAL OF IMMUNOLOGY (2011)
Dexamethasone attenuates development of monocrotaline-induced pulmonary arterial hypertension
Wei Wang et al.
MOLECULAR BIOLOGY REPORTS (2011)
Interleukin(IL)-4 promotion of CXCL-8 gene transcription is mediated by ERK1/2 pathway in human pulmonary artery endothelial cells
Dao-Feng Yang et al.
MOLECULAR IMMUNOLOGY (2011)
Mechanisms of disease: pulmonary arterial hypertension
Ralph T. Schermuly et al.
NATURE REVIEWS CARDIOLOGY (2011)
Pressure Load: The Main Factor for Altered Gene Expression in Right Ventricular Hypertrophy in Chronic Hypoxic Rats
Jonas D. Baandrup et al.
PLOS ONE (2011)
Hypoxic Pulmonary Hypertension in Mice with Constitutively Active Platelet-Derived Growth Factor Receptor-β
Bhola K. Dahal et al.
Pulmonary Circulation (2011)
Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
Bhola K. Dahal et al.
RESPIRATORY RESEARCH (2011)
Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats
Lunyin Yu et al.
RESPIRATORY RESEARCH (2011)
Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension
Peter Dorfmueller et al.
RESPIRATORY RESEARCH (2011)
Contribution of CXCR4+/PDGFRβ+ progenitor cells in hypoxic alveolar arterioles muscularization: role of myocardin
Wei Jie et al.
CARDIOVASCULAR RESEARCH (2010)
Atorvastatin Decreases C-Reactive Protein-Induced Inflammatory Response in Pulmonary Artery Smooth Muscle Cells by Inhibiting Nuclear Factor-kappa B Pathway
Jie Li et al.
CARDIOVASCULAR THERAPEUTICS (2010)
Altered Immune Phenotype in Peripheral Blood Cells of Patients with Scleroderma-Associated Pulmonary Hypertension
Michael G. Risbano et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice
Michele M. Hickey et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells
Akiko Yagami et al.
JOURNAL OF IMMUNOLOGY (2010)
The Role of the CCL2/CCR2 Axis in Mouse Mast Cell Migration In Vitro and In Vivo
Sarah J. Collington et al.
JOURNAL OF IMMUNOLOGY (2010)
CXC-Chemokine Ligand 10 in Idiopathic Pulmonary Arterial Hypertension: Marker of Improved Survival
Gustavo A. Heresi et al.
LUNG (2010)
Adiponectin Deficiency Increases Allergic Airway Inflammation and Pulmonary Vascular Remodeling
Benjamin D. Medoff et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
High Pulsatility Flow Induces Adhesion Molecule and Cytokine mRNA Expression in Distal Pulmonary Artery Endothelial Cells
Min Li et al.
ANNALS OF BIOMEDICAL ENGINEERING (2009)
Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension
Karen C. Young et al.
CIRCULATION RESEARCH (2009)
Hemodynamic Instability after Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension Correlates with Cytokine Network Hyperstimulation
J. Lindner et al.
EUROPEAN SURGICAL RESEARCH (2009)
Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells
Paul D. Upton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice
Yanli Song et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension
Christine M. Costello et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats
John Zagorski et al.
PHYSIOLOGICAL GENOMICS (2008)
Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats
John Zagorski et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension
Olivier Sanchez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle
Moira Hagen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
F. Perros et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats
John A. Watts et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Epoprostenol therapy decreases elevated circulating levels of monocyte chemoattractant protein-1 in patients with primary pulmonary hypertension
K Hashimoto et al.
CIRCULATION JOURNAL (2004)
Soluble CD40 ligand in pulmonary arterial hypertension -: Possible pathogenic role of the interaction between platelets and endothelial cells
JK Damås et al.
CIRCULATION (2004)
The state of GPCR research in 2004
T Bartfai et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The disintegrin-like metalloproteinase ADAM 10 is involved in coinstitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion
C Hundhausen et al.
BLOOD (2003)
Role of endothelial MCP-1 in monocyte adhesion to inflamed human endothelium under physiological flow
U Maus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats
Y Ikeda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
CX3C chemokine fractalkine in pulmonary arterial hypertension
K Balabanian et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension
H Kimura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3
P Loetscher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells
S Molet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)